Search Login Register
Chlorambucil
(Leukeran)
Summary
Description:
A nitrogen mustard alkylating agent used as antineoplastic for chronic lymphocytic leukemia, Hodgkin's disease, and others. Although it is less toxic than most other nitrogen mustards, it has been listed as a known carcinogen in the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (Merck Index, 11th ed)
Also Known As:
Leukeran; 4-(Bis(2-chloroethyl)amino)benzenebutanoic Acid; Amboclorin; CB-1348; Chloraminophene Show All >>
Networked: 1141
relevant articles (130 outcomes,
160 trials/studies)
for this Drug
Key Diseases for which Chlorambucil is
Relevant
-
Nephrotic Syndrome (Syndrome, Nephrotic)
:
26 outcomes 8 studies in 76 results
-
B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
:
22 outcomes 35 studies in 176 results
-
Membranous Glomerulonephritis (Membranous Nephropathy)
:
14 outcomes 10 studies in 44 results
-
Neoplasms (Cancer)
:
12 outcomes 21 studies in 123 results
-
Lymphoma (Lymphomas)
:
8 outcomes 14 studies in 72 results
Show All >>
Drugs Related to Chlorambucil
-
Cyclophosphamide (Cytoxan)
-
Prednisone (Sone)
-
Prednisolone (Predate)
-
Methylprednisolone
-
fludarabine
-
rituximab (Mabthera)
-
Vincristine (Oncovin)
-
Procarbazine (Matulane)
-
Vinblastine (Vinblastine Sulfate)
-
Doxorubicin (Adriamycin)
Show All >>
Therapies Related to Chlorambucil
-
Drug Therapy (Chemotherapy)
-
Combination Drug Therapy (Combination Chemotherapy)
-
Radiotherapy
-
Aftercare (After-Treatment)
-
Plasmapheresis
Show All >>
CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.